Page:United States Statutes at Large Volume 121.djvu/2521

 121 STAT. 2500

PUBLIC LAW 110–173—DEC. 29, 2007

appropriate, of $35,000,000 to the Centers for Medicare & Medicaid Services Program Management Account for the period of fiscal years 2008, 2009, and 2010. SEC. 112. PAYMENT FOR PART B DRUGS.

dkrause on GSDDPC44 with PUBLAW

Effective date.

VerDate Aug 31 2005

07:12 Jan 26, 2009

(a) APPLICATION OF ALTERNATIVE VOLUME WEIGHTING IN COMPUTATION OF ASP.—Section 1847A(b) of the Social Security Act (42 U.S.C. 1395w–3a(b)) is amended— (1) in paragraph (1)(A), by inserting ‘‘for a multiple source drug furnished before April 1, 2008, or 106 percent of the amount determined under paragraph (6) for a multiple source drug furnished on or after April 1, 2008’’ after ‘‘paragraph (3)’’; (2) in each of subparagraphs (A) and (B) of paragraph (4), by inserting ‘‘for single source drugs and biologicals furnished before April 1, 2008, and using the methodology applied under paragraph (6) for single source drugs and biologicals furnished on or after April 1, 2008,’’ after ‘‘paragraph (3)’’; and (3) by adding at the end the following new paragraph: ‘‘(6) USE OF VOLUME-WEIGHTED AVERAGE SALES PRICES IN CALCULATION OF AVERAGE SALES PRICE.— ‘‘(A) IN GENERAL.—For all drug products included within the same multiple source drug billing and payment code, the amount specified in this paragraph is the volumeweighted average of the average sales prices reported under section 1927(b)(3)(A)(iii) determined by— ‘‘(i) computing the sum of the products (for each National Drug Code assigned to such drug products) of— ‘‘(I) the manufacturer’s average sales price (as defined in subsection (c)), determined by the Secretary without dividing such price by the total number of billing units for the National Drug Code for the billing and payment code; and ‘‘(II) the total number of units specified under paragraph (2) sold; and ‘‘(ii) dividing the sum determined under clause (i) by the sum of the products (for each National Drug Code assigned to such drug products) of— ‘‘(I) the total number of units specified under paragraph (2) sold; and ‘‘(II) the total number of billing units for the National Drug Code for the billing and payment code. ‘‘(B) BILLING UNIT DEFINED.—For purposes of this subsection, the term ‘billing unit’ means the identifiable quantity associated with a billing and payment code, as established by the Secretary.’’. (b) TREATMENT OF CERTAIN DRUGS.—Section 1847A(b) of the Social Security Act (42 U.S.C. 1395w–3a(b)), as amended by subsection (a), is amended— (1) in paragraph (1), by inserting ‘‘paragraph (7) and’’ after ‘‘Subject to’’; and (2) by adding at the end the following new paragraph: ‘‘(7) SPECIAL RULE.—Beginning with April 1, 2008, the payment amount for—

Jkt 059194

PO 00002

Frm 01208

Fmt 6580

Sfmt 6581

M:\STATUTES\2007\59194PT2.001

APPS10

PsN: 59194PT2

�